Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
KRT9 encodes the type I keratin 9, an intermediate filament chain expressed only in the terminally differentiated epidermis of palms and soles.
Showing 4 out of 14 products:
Human KRT9 ELISA Kit for Sandwich ELISA - ABIN417500
Richens, Spencer, Butler, Cantlay, Vere, Bajaj, Morgan, OShea: Rationalising the role of Keratin 9 as a biomarker for Alzheimer's disease. in Scientific reports 2016
During analyzing the sequences of KRT9 gene of a epidermolytic palmoplantar keratoderma (EPPK) pedigree, we found a new heterozygous missense mutation (488G>T) of exon 1 of KRT9 gene, which has not been reported before and does not exist in healthy individuals of the family and 100 unrelated individuals.
Results identified the missense mutation KRT9 c.487C>T, as a potential causative mutation in the large Uygur family with epidermolytic palmoplantar keratoderma.
KRT9 expression is significantly downregulated in human masticatory mucosa during wound healing
Findings suggest that dysregulated Keratin 9 expression is a consequence of Alzheimer's disease (AD).
Mutational analysis revealed a T to G transition in the coding DNA sequence, designated as c.470T>G (p.Met157Arg), a missense mutation in exon 1 of KRT9 in the proband and her brother, but not in unrelated healthy controls.
KRT9 gene mutation as a reliable indicator in the prenatal molecular diagnosis of epidermolytic palmoplantar keratoderma.
A heterozygous missense mutation c.482A to G in the KRT9 gene.
We identified a novel Eidermolytic Palmoplantar Keratoderma-causing mutation located in a region of the KRT9 gene, encoding a poorly conserved region of the protein that is not routinely screened for diagnostic purposes.
Data indicate that the node tumour burden could be accurately quantified based on the cytokeratin 19 (CK19 (show KRT19 ELISA Kits)) mRNA copy number.
A heterozygous transversional mutation, 488G-->A, was identified in exon 1 of KRT9 gene in all patients.
Intron 6 influences the transcriptional efficiency of the keratin 9 (K9, Krt1-9) gene by decreasing production of wild-type K9 and changing the expression of K9 proteins.
This gene encodes the type I keratin 9, an intermediate filament chain expressed only in the terminally differentiated epidermis of palms and soles. Mutations in this gene cause epidermolytic palmoplantar keratoderma.
, keratin 9 (epidermolytic palmoplantar keratoderma)
, cytokeratin 9
, keratin, type I cytoskeletal 9
, type I cytoskeletal 9
, keratin complex 1, acidic, gene 9
, spermatid perinuclear ring manchette protein K9